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Chymotryptic digestion of chicken gizzard light meromyosin (LMM) produced a 72 kDa core fragment, 
which was fully soluble at 150 mM KCI. pH 6.5-7.5. The fragment showed weak self-association at 50 mM 
KCI. The homology of the N-terminus amino acid sequence of this fragment with the sequence of the rabbit 
skeletal myosin rod suggested that the N-terminus of the core fragment originated 5 kDa from the hinge 
common to both smooth and skeletal myosin rod. Sedimentation experiments indicated that the domain 
specifying the insolubility of the intact LMM was 13 kDa long. Progressive proteolytic shortening of this 
region produced LMM fragments of progressively increasing solubility. Electron microscopy of segments 
formed from full-length LMM and from LMM core suggested that this 13 kDa domain specified the 43 
nm parallel and antiparallel molecular overlaps characteristic of self-assembled intact myosin. 
(Smooth muscle) Myosin Myosin self-assembly Filament-monomer 
1. INTRODUCTION 
Smooth muscle myosin has remarkable solubili- 
ty properties, being able at physiological ionic 
strength to adopt either a soluble, folded con- 
figuration [1,2] or an extended configuration 
which assembles into filaments [3]. Several recent 
reports describe narrow domains within the light 
meromyosin (LMM) domains of other myosins 
which are critical for filament formation [4-81. 
Here we describe an apparently analogous region 
within chicken gizzard LMM, the removal or par- 
tial removal of which profoundly alters the 
solubility properties of the molecule. 
2. MATERIALS AND METHODS 
Purified chicken gizzard myosin was used as a 
source of LMMs. The 90 kDa LMM chain was 
prepared by digesting 12 mg-ml-’ myosin with 
0.1 mg *ml-’ chymotrypsin in a buffer of 0.6 M 
KCI, 2 mM MgClz, 1 mM cysteine and 10 mM im- 
idazole, pH 7.2, for 10 min at 25”C, adding 
phenylmethanesulphonyl fluoride (in 96% 
ethanol) to 1 mM final concentration, denaturing 
with 2 vols cold 96% ethanol, pelleting (22000 x g, 
20 min), resuspending in the digestion buffer, 
clarifying (55000 x g, 60 min), dialysing to 20 mM 
KCI, 1 mM MgClz, 0.5 mM cysteine and 5 mM 
imidazole, pH 6.5, and pelleting the resulting ag- 
gregates. For amino acid sequence analysis, the 
resulting preparation was redissolved in the diges- 
tion buffer and gel filtered in the same buffer 
(FPLC; Superose 6, Pharmacia). The leading frac- 
tions were pooled, dialysed against 0.6 M am- 
monium formate and lyophilised. The 72 kDa 
soluble LMM was prepared by further digestion of 
this preparation for 120 min at 25°C using 
0.05 mg - ml-’ cu-chymotrypsin and the same diges- 
tion buffer. The stopped digest was dialysed to 
60 mM KCI, 2 mM MgClz, 1 mM cysteine and 
10 mM imidazole, pH 6.5, and centrifuged at 
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150000 x g for 20 min. The su~rnatants were 
pooled and purified using FPLC as above. 
For amino acid analysis, 1OOgg of each frag- 
ment were loaded on a gas-phase sequinator (Ap- 
plied Biosystems Inc., USA), assembled and 
operated as described [lo]. The stepwise liberated 
phenylthiohydantoin (PTH)-amino acid deriva- 
tives were identified using a Cyano-HPLC analyti- 
cal column (IBM) and the gradient elution de- 
scribed in [ 1 l] . We used a Waters HPLC system in- 
cluding two M6000 pumps, a WISP 710B autoin- 
jector, an M721 system controller and an M441 
fixed wavelength detector. The recovery of the 
PTH-amino acids was measured at each cycle us- 
ing an integrative recorder (Waters data module 
M730). 
3. RESULTS 
3.1. Solubiiities of LMM fragments 
The tail or rod of smooth muscle myosin can be 
cleaved by chymotrypsin at or very close to a hinge 
region [12] generating a 40 kDa chain, subfrag- 
ment 2 (SF 2), which is soluble at physiological 
ionic strength and a 90 kDa LMM chain, which is 
insoluble. Although the 90 kDa LMM is resistant 
in the short term to further digestion f13], pro- 
longed incubation produced a range of truncated 
LMMs of decreasing molecular mass down to 
72 kDa (fig. 1). Samples of this digest were dialysed 
into buffers of two ionic strengths and various 
pHs, and separated into soluble and insoluble frac- 
tions by sedimentation in an airfuge (fig.1). At 
8 s 
Yi!i -150 mM KCI - - 5~rn~ KCI - 
sib - PELL- I---SNT- -PELL - --NT- 
/ 
I eP 
Fig, 1. 1 l-22% microslab gradient PAGE showing segmentation of whole digest of chicken gizzard LMM as a function 
of ionic strength and pH. Flanking lanes, molecular mass markers (in kDa): myosin, 205; &galactosidase, 116; 
phosphorylase b,94; bovine serum albumin, 67; ovalbumin, 45; carbonic anhydrase, 29. The next two lanes on the left 
show respectively the source LMM and a 2 h chymotryptic digest performed in 0.6 M KCl, 1 mM cysteine, 1 mM MgCl2 
and 10 mM imidazole, pH 7.2, at 25°C and a 1: 100 enzyme/substrate ratio. The blocks labelled SNT and PELL 
represent he peptide compositions of the supernatants and pellets of this digest following dialysis of 200 ~1 samples 
of the digest to either 150 mM KC1 or 50 mM KCl, 10 mM imidazole, 1 mM MgClz, 1 mM cysteine, pH 6.5-7.5, and 
centrifugation in the airfuge at 150000 x g for 20 min. Supernatants were diluted with 1 vol. SDS buffer (17.5% SDS, 
7% &mercaptoethanol, 0.437 M Tris, pH 6.8). Pellets were dissolved in this buffer and adjusted to the same volume 
as the supernatant samples. The gels [20,21] are thus quantitative. 
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150 mM KCl, the original 90 kDa LMM was com- 
pletely sedimented, whereas the 72 kDa fragment 
remained in the supernatant over the pH range 
6.5-7.5. The removal of 18 kDa from the original 
90 kDa LMM chains was thus sufficient to render 
the molecule soluble at physiological ionic 
strength. Intermediate sized fragments had in- 
termediate solubility properties. If the experiment 
was repeated at 50 mM KCl, most of the in- 
termediate size material was pelleted together with 
some of the 72 kDa LMM. The greater part of this 
72 kDa material nonetheless remained in the 
supernatant fraction, particularly at high pH 
(fig. 1). 
3.2. N-terminal amino acid sequencing 
To establish the location of the soluble 72 kDa 
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Fig.2. (A) N-terminal amino acid sequences of 90 and 
72 kDa chain chicken gizzard LMMs. (B) Alignment of 
72 kDa LMM N-terminus with the known rabbit skeletal 
myosin rod sequence. Amino acid residues are 
designated by the one letter notation. An X indicates an 
ambiguous assignment. Homologous residues are 
boxed. Those marked with an asterisk occur at the 
hydrophobic interfaces between adjacent chains. The 
most likely alignment indicates that the 72 kDa LMM 
core arises by cleavage of 5 kDa from the N-terminus 
and 13 kDa from the C-terminus of the parent 90 kDa 
LMM chain. 
LMM core fragment within the parent 90 kDa 
LMM, we performed N-terminal amino acid se- 
quencing of the purified fragments (fig.2). The two 
N-termini were nonidentical, indicating some loss 
of material from the 90 kDa N-terminus in 
generating the 72 kDa. The amino acid sequence 
of the gizzard myosin-rod has not yet been deter- 
mined, and so we searched for homology of the se- 
quences to the known rabbit skeletal myosin se- 
quence [14,15]. A search of the rabbit data be- 
tween the hinge region and residue 484 of the rod 
produced a unique fit for the N-terminus of the 
gizzard 72 kDa LMM fragment starting at residue 
379 of the rabbit sequence, about 5 kDa from the 
hinge common to gizzard and myosin rods (fig.2). 
At this position 5 out of 12 residues matched. This 
degree of homology is similar to that observed for 
the best fit of rabbit LMM fragments to the 
nematode data [5]. The present assignment, if cor- 
rect, implies that all 5 amino acid identities are on 
the charged outside surface of the coiled coil, away 
from the hydrophobic seam, and also that 5 kDa 
of sequence has been lost from the N-terminus of 
intact LMM in generating the 72 kDa LMM core. 
We were unable to align unambiguously the giz- 
zard data with the nematode sequence, or to fit the 
90 kDa gizzard LMM N-terminus unambiguously 
against the rabbit sequence. Purely on the basis of 
molecular length, however, this must lie close to 
the hinge [12]. 
3.3. Size of the solubility-determining domain 
The gels in fig.1 indicate that the 90 kDa LMM 
could be shortened to 85 kDa without affecting its 
solubility properties. Further, LMM fragments in- 
termediate in size between 85 and 72 kDa show a 
progressive change in solubility, indicating that the 
whole of the 13 kDa difference piece is involved in 
modulating the ability to self-assemble. If, as 
seems likely, this material forms a continuous 
solubility-determining domain within the myosin 
rod, then the sequence data require that it maps to 
the C-terminus of the molecule, with the N- 
terminus of 72 kDa LMM therefore 5 kDa from 
the hinge (fig.2). 
3.4. Segment formation 
Gizzard myosin rod and LMM form 
characteristic segments [ 161 when precipitated with 
divalent metal ions from KSCN-containing buf- 
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fem. The segments are characterised by specific 
43 nm molecular overlaps, occurring with adjacent 
molecules both antiparallel and parallel. To throw 
further light on the origin of the 13 kDa of 
solubility-determining material within the full- 
length LMM chain, the segment forming proper- 
ties of the 90 kDa and 72 kDa LMMs were com- 
pared. As shown in fig.3A, the 90 kDa LMM 
formed compound segments as expected, ex- 
hibiting both the 43 nm parallel and antiparallel 
molecular staggers. Low numbers of segments 
showing apparently only the parallel overlap were 
also observed (fig.3B). For the 72 kDa LMM, the 
order of the segments was disrupted, a large 
amount of loosely-aggregated material appearing 
on the grids, together with larger but poorly 
ordered segments (fig.3C,D). These appeared to 
arise as a result of side by side association of 
molecules, followed by loose end-to-end abutment 
of these parallel assemblies. 
In the absence of the 13 kDa solubility- 
determining material segment assembly is thus 
disrupted, and the ability to make the 43 nm 
molecular staggers lost. This domain seems 
therefore to be responsible both for self assembly 
per se, and for the definition of the molecular stag- 
gers exhibited by self-assembled intact myosin 
molecules. 
4. DISCUSSION 
The above results demonstrate that a 13 kDa 
section of gizzard LMM plays a crucial role in 
determining the ability of the molecule to self- 
assemble at physiological ionic strength, and in 
defining the specific parallel and antiparallel 
Fig.3. LMM segments. Segments were formed from 90 kDa (A,B) and 72 kDa (C,D) LMMs by dialysis of a 1 mgeml-’ 
solution of the proteins in 0.6 M KC1 to 85 mM KSCN, 50 mM CaC12, 50 mM Tris, pH 8.2 [la]. Negative staining was 
done at room temperature on 400 mesh carbon-coated Cu grids, using 1% aqueous uranyl acetate. The micrographs 
were all obtained at a nominal magnification of 36000 x using a Zeiss EM 10 operated at 80 kV. The period of the 
segment in (B) is 43 nm, using the 40 nm repeat of tropomyosin paracrystals as a calibration standard. 
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molecular overlaps characteristic of segments. The 
13 kDa might produce its effects on solubility 
either directly, by binding itself to neighbouring 
molecules, or indirectly, by straining the confor- 
mation of the remainder of the LMM so as to in- 
duce the property of self-association. In this latter 
case, however, one might expect cleavage within 
the 13 kDa region to produce a step change in 
solubility as the critical strain-inducing region was 
cleaved. Instead, we observed a gradual increase in 
solubility according to the degree of truncation of 
the solubility-determining 13 kDa region. This in- 
dicates that the 13 kDa region itself makes specific 
binding interactions with other molecules. In this 
case the 13 kDa solubility-determining domain 
must be located at the C-terminus of the molecule, 
since it cannot otherwise specify the 43 nm an- 
tiparallel molecular overlap of the segments. This 
argument leads to the same conclusion as reached 
on the basis of amino acid sequence homology, 
that the solubility-determining 13 kDa domain is 
located at the C-terminus of the smooth muscle 
myosin molecule. For skeletal myosin, a similar 
solubility-determining region of only 5 kDa has 
been reported [5], and assigned to a site close to the 
C-terminus of the molecule. The site of this do- 
main aligns with the forward part of that deduced 
here for the smooth muscle myosin molecule 
(fig.2). 
mainder of the molecule being essentially 
unrestrained. Under such conditions, filament 
disassembly to form 10 S (folded) monomers is 
favoured, particularly in the presence of ATP 
[1,2]. In contrast, at lower ionic strengths we 
detected limited self-association along the entire 
length of LMM (fig.1). The filaments would then 
be expected to have a tighter structure, with 
disassembly being disfavoured. Filament disassem- 
bly is indeed inhibited under these conditions, even 
in the presence of ATP [17]. It is further possible 
that ionic strength-dependent binding occurs be- 
tween different sections of LMM within single 
folded myosin monomers. It was recently shown 
that under low ionic strength conditions, the tail 
loop of the folded molecules closes, the sections of 
the tail appearing to bind to one another, and the 
molecules tending to dimerize [18]. A scheme in- 
corporating these points is shown in fig.4. 
In vitro at physiological ionic strength (150 mM 
KCl, pH 7.0), unphosphorylated smooth muscle 
myosin filaments are unstable. Addition under 
these conditions of stoichiometric amounts of 
ATP is sufficient to disassemble these filaments 
completely to form folded monomers, in which the 
tail of the molecule folds back on itself to contact 
the heads. By contrast at lower pH and ionic 
strength (50 mM KCl, pH 6.5) little filament 
disassembly occurs [ 171. The present results sug- 
gest a partial explanation for this solubility 
behaviour. The pelleting experiments how that at 
150 mM KCl, significant intermolecular binding 
occurs only between molecules containing all or 
part of the 13 kDa solubility-determining domain. 
In contrast, at 50 mM KC1 we detected self- 
association along the entire length of the LMM. 
Extending these findings to the thick filament, we 
imagine myosin filaments at physiological ionic 
strength to be stabilized purely by binding interac- 
tions involving the C-terminal sticky patch, the re- 
Fig.4. Outline model for the filament-to-10 S monomer 
transition of smooth muscle myosin. The scheme shown 
represents an attempt to relate the present findings to the 
known solution behaviour of smooth muscle myosin. At 
intermediate KC1 concentrations (upper), the myosin 
filaments are supposed to be stabilised purely by binding 
interactions involving the C-terminal tailpiece domains 
of the molecules. These conditions favour filament 
dissociation, particularly in the presence of ATP [17]. 
The folded monomers so formed [ 1,2] have an open tail 
loop [18]. At lower ionic strength, the filaments are 
postulated to have a tighter structure, the full length of 
the LMM being held against the filament surface, and 
the filaments are resistant to dissolution [ 171. Similarly, 
the tail loop of the folded monomers closes at low ionic 
strength [ 181, suggesting that salt-dependent binding 
occurs between different sections of the LMM within 
May 1986 
one molecule. 
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Whilst this work was in progress, Tashiro et al. 
[19] reported a soluble 74 kDa gizzard LMM, but 
were unable to localize it within the myosin rod. 
ACKNOWLEDGEMENTS 
R.C. wishes to thank his colleagues in Salzburg, 
particularly J.V. Small, for helpful discussions. 
We acknowledge also the valuable assistance of J. 
Van Damme during amino acid sequencing. R.C. 
is a Fellow of the European Molecular Biology 
Organization (EMBO), and J.V. a Research 
Associate of the Belgian National Fund for Scien- 
tific Research (NFWO). Part of this work was sup- 
ported by grants from the Muscular Dystrophy 
Association of America and the Austrian Fonds 
zur Forderung der Wissenschaftlichen Forschung. 
REFERENCES 
[l] Suzuki, H., Kamata, T., Onishi, H. and Watanebe, 
S. (1982) J. Biochem. (Tokyo) 91, 1699-1705. 
[2] Trybus, K.M., Huiatt, T.W. and Lowey, S. (1982) 
Proc. Natl. Acad. Sci. USA 79, 6151-6155. 
[3] Craig, R., Smith, R. and Kendrick-Jones, J. (1983) 
Nature 302, 436-439. 
[4] Akutagawa, T. and Ooi, T. (1982) J. Biochem. 
(Tokyo) 92, 999-1007. 
[5] Nyitray, L., Molz, G., Szilagyi, L., Balint, M., Lu, 
R.C., Wong, A. and Gergely, J. (1983) J. Biol. 
Chem. 258, 13213-13220. 
[6] Kiehart, D. and Pollard, T. (1984a) J. Cell Biol. 99, 
1015-1023. 
[7] Kiehart, D. and Pollard, T. (1984b) Nature 308, 
864-866. 
[8] Pagh, K., Maruta, H., Claviez, M. and Gerisch, G. 
(1984) EMBO J. 3, 3271-3278. 
[9] Sobieszek, A. (1985) Biochemistry 24, 1266-1274. 
[lo] Hewick, R.M., Hunkapillar, M.W., Hood, L.E. 
and Dreyer, W.J. (1981) J. Biol. Chem. 256, 
7990-7997. 
[ll] Hunkapillar, M.W. and Hood, L.E. (1983) 
Methods Enzymol. 91, 486-493. 
1121 Cross. R.A. (1984) FEBS Lett. 176. 197-201. 
i13j 
(141 
1151 
1161 
H71 
1181 
v91 
WI 
WI 
Cross: R.A.; Bardsley, R.G., Ledward, D.A., 
Small, J.V. and Sobieszek, A. (1984) Eur. J. Bio- 
them. 145, 305-310. 
McLachlan, A.D. and Karn, J. (1982) Nature 299, 
226-23 1. 
Lu, R.C. and Wong, A. (1985) J. Biol. Chem. 260. 
3456-3461. 
Kendrick-Jones, J., Szent Gyorgyi, A.G. and 
Cohen, C. (1971) J. Mol. Biol. 59, 527-529. 
Kendrick-Jones, J., Cande, W.Z., Tooth, P.J., 
Smith, R.C. and Scholey, J.M. (1983) J. Mol. Biol. 
165, 139-162. 
Trybus, K.M. and Lowey, S. (1984) J. Biol. Chem. 
259, 8564-8571. 
Tashiro, Y., Kumon, A., Yasuda, S., Murakami, 
N. and Matsumura, S. (1985) Eur. J. Biochem. 
148, 521-528. 
Laemmli, U.K. (1970) Nature 227, 680-685. 
Matsudaira, P.T. and Burgess, D.R. (1978) Anal. 
Biochem. 87, 386-396. 
360 
